首页> 外文会议>Annual meeting exposition of the Controlled Release Society >The Co-Delivery of Paclitaxel and Herceptin Using Cationic Micellar Nanoparticles
【24h】

The Co-Delivery of Paclitaxel and Herceptin Using Cationic Micellar Nanoparticles

机译:使用阳离子胶束纳米颗粒共转运紫杉醇和赫赛汀

获取原文

摘要

We have recently reported micellar nanoparticles selfassembledfrom a biodegradable and amphiphiliccopolymer poly{N-methyldietheneamine sebacate)-co-[(cholesteryl oxocarbonylamido ethyl) methylbis(ethylene) ammonium bromide] sebacate} P(MDS-co-CES), which were able to deliver small molecular drugsand biomacromolecules such as genes and functionalproteins individually or simultaneously into various typesof cells. In this study, these cationic micellarnanoparticles were employed as carriers to co-deliverpaclitaxel and Herceptin for achieving targeted deliveryof paclitaxel to HER2-overexpressing human breastcancer cells, as well as enhancing cytotoxicity throughsynergistic activities. Cellular response to our treatmentapproach was dependent on the HER2 expression level.Targeting properties of the nanocomplexes was displayedthrough significantly higher cellular uptake andcytotoxicity of the nanocomplexes in HER2-overexpressing BT474 compared to HER2-negativeHEK293 cells.
机译:我们最近报道了胶束纳米颗粒自组装 来自可生物降解和两亲的 共聚物聚(N-甲基二乙二胺癸二酸酯)-共聚物- [(胆固醇羰基羰基酰胺基乙基)甲基 双(乙烯)溴化铵]癸二酸酯} P(MDS-co- CES),能够提供小分子药物 和生物大分子,例如基因和功能 蛋白质单独或同时分为各种类型 细胞。在这项研究中,这些阳离子胶束 纳米颗粒被用作载体以共同递送 紫杉醇和赫赛汀可实现靶向递送 紫杉醇对过量表达HER2的人乳房的影响 癌细胞,并通过增强细胞毒性 协同活动。细胞对我们治疗的反应 方法取决于HER2表达水平。 显示了纳米复合物的靶向特性 通过明显更高的细胞摄取和 纳米复合物在HER2中的细胞毒性 与HER2阴性相比过表达BT474 HEK293细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号